HLB Therapeutics Co.,Ltd.
115450
Classement en actions
#18260
HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the... HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the creation of pharmaceutical products for both the South Korean and international markets. A significant part of its research and development initiatives includes GBT-201, a compound utilizing Thymosin beta designed to treat various eye ailments such as dry eye syndrome and neurotrophic keratopathy. Additionally, the company is advancing OKN-007 as a potential therapy for glioblastoma brain tumors. Beyond its pharmaceutical endeavors, HLB Therapeutics is also involved in the wholesale distribution of vaccines and the production of electrical and electronic components like motors, pumps, and transformers. The company, which established its roots in 2000 and is based in Seongnam, South Korea, underwent a name change in December 2021, transitioning from its former identity as G-treeBNT Co., Ltd. to its current designation.
Prix de l'action
$2.02
Capitalisation boursière
$190.66M
Changement (1 jour)
7.96%
Changement (1 an)
-1.16%
Pays
KR
Échange HLB Therapeutics Co.,Ltd. (115450)
Catégorie
Healthcare
Nombre d'actions en circulation pour HLB Therapeutics Co.,Ltd. (115450)
Nombre d'actions en circulation au October 2026: 0
Selon les derniers rapports financiers et le cours de l'action de HLB Therapeutics Co.,Ltd., le nombre actuel d'actions en circulation est de 0. À la fin de October 2026, l'entreprise avait 0 actions en circulation. Le nombre d'actions en circulation est généralement affecté par les divisions d'actions et les rachats d'actions.
Historique des actions en circulation de HLB Therapeutics Co.,Ltd. (115450) de 2016 à 2026
Actions en circulation à la fin de chaque année
| Année | Actions en circulation | Changez |
|---|---|---|
| 2025 | 83.90M | 1.29% |
| 2024 | 82.83M | 15.58% |
| 2023 | 71.66M | 8.55% |
| 2022 | 66.02M | 12.94% |
| 2021 | 58.45M | 7.26% |
| 2020 | 54.50M | 2.98% |
| 2019 | 52.92M | 7.01% |
| 2018 | 49.46M | 3.77% |
| 2017 | 47.66M | 6.05% |
| 2016 | 44.94M | 0.00% |
Actions en circulation pour des entreprises similaires ou concurrentes
| Entreprise | Actions en circulation | Différence | Pays |
|---|---|---|---|
| 253.90M | - |
US
|
|
| 396.00M | - |
US
|
|
| 478.91M | - |
AU
|
|
| 62.19M | - |
NL
|
|
| - | - |
CH
|
